SpyGlass Pharma, Inc. (SGP)
25.87
-0.55
(-2.08%)
USD |
NASDAQ |
Aug 31, 11:26
SpyGlass Pharma Market Cap : 865.26M for Aug. 31, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 883.65M |
| August 27, 2026 | 900.71M |
| August 26, 2026 | 891.01M |
| August 25, 2026 | 889.67M |
| August 24, 2026 | 878.30M |
| August 21, 2026 | 886.66M |
| August 20, 2026 | 877.30M |
| August 19, 2026 | 910.74M |
| August 18, 2026 | 864.25M |
| August 17, 2026 | 862.25M |
| August 14, 2026 | 876.29M |
| August 13, 2026 | 841.84M |
| August 12, 2026 | 845.19M |
| August 11, 2026 | 831.14M |
| August 10, 2026 | 841.51M |
| August 07, 2026 | 846.53M |
| August 06, 2026 | 827.80M |
| August 05, 2026 | 792.01M |
| August 04, 2026 | 806.39M |
| August 03, 2026 | 758.25M |
| July 31, 2026 | 753.24M |
| July 30, 2026 | 759.59M |
| July 29, 2026 | 732.51M |
| July 28, 2026 | 722.81M |
| July 27, 2026 | 696.07M |
| Date | Value |
|---|---|
| July 24, 2026 | 685.03M |
| July 23, 2026 | 698.07M |
| July 22, 2026 | 686.71M |
| July 21, 2026 | 677.68M |
| July 20, 2026 | 669.32M |
| July 17, 2026 | 660.96M |
| July 16, 2026 | 694.06M |
| July 15, 2026 | 688.71M |
| July 14, 2026 | 668.32M |
| July 13, 2026 | 665.31M |
| July 10, 2026 | 752.90M |
| July 09, 2026 | 670.99M |
| July 08, 2026 | 684.03M |
| July 07, 2026 | 652.60M |
| July 06, 2026 | 638.23M |
| July 02, 2026 | 640.23M |
| July 01, 2026 | 650.93M |
| June 30, 2026 | 744.21M |
| June 29, 2026 | 723.82M |
| June 26, 2026 | 708.10M |
| June 25, 2026 | 628.87M |
| June 24, 2026 | 653.61M |
| June 23, 2026 | 657.62M |
| June 22, 2026 | 646.59M |
| June 18, 2026 | 625.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.667B |
| Corcept Therapeutics, Inc. | 12.14B |
| Veru, Inc. | 46.04M |
| Johnson & Johnson | 641.67B |
| Eli Lilly & Co. | 1.089T |
Market Cap Related Metrics
| Price to Book Value | 3.724 |
| Price | 25.87 |
| Earnings Yield | -7.43% |